Registration

Session 1: Research opportunities in China

Infectious disease research

• Chairpersons: Zhu Chen, Vice-President, Chinese Academy of Sciences and Beth Seidenberg, Partner, Kleiner Perkins Caufield & Byers

• David Ho,
  Director & CEO, Aaron Diamond AIDS Research Center;
  Irene Diamond Professor, The Rockefeller University
  “'Vaccine Development for HIV-1 and H5N1 Influenza”
• Zihe Rao,
  President, Nankai University
  “Structural Proteomics of the SARS Coronavirus: Insights into the Replication Machinery”
• Yi Guan,
  Department of Microbiology, The University of Hong Kong
  “Recent development of H5N1 influenza virus in China”

Stem Cell Research

• Chairpersons: Paul Huang, Associate Director, Cardiovascular Research Center at Massachusetts General Hospital and Myles Axton, Editor, Nature Genetics

• Douglas Melton,
  Co-Director of the Harvard Stem Cell Institute, Department of Molecular and Cellular Biology, Harvard University, HHMI
  “Pancreatic Stem Cells for Organ Development and Reconstruction”

• Jerry Yang,
  Center for Regenerative Biology, University of Connecticut
  “Somatic Cell Nuclear Reprogramming - From There to Here”
• Huizhen Sheng,
  Center for Developmental Biology, Xinhua Hospital, China
  “Nuclear Reprogramming - The Experiment and the Mechanism”
• Kenneth R Chien,
  Director Cardiovascular Research Center, Massachusetts General Hospital; Department of Cell Biology, Harvard Medical School, and Harvard Stem Cell Institute
  “Master Heart Progenitor Cells: Towards Human Models of Human Cardiovascular Diseases”

Chemical Biology

• Chairpersons: Douglas Melton, Co-Director of the Harvard Stem Cell Institute, Department of Molecular and Cellular Biology, Harvard University, HHMI and Chi-Ming Che, Department of Chemistry, The University of Hong Kong

• David Wong,
  School of Medicine, Indiana University, USA
  “Mechanisms to Augment Antidepressive Effects of Current Medications”
• Hua-Liang Jiang,
  Shanghai Institute of Materia Medica, Chinese Academy of Science
  “What Can Chemical Biology Provide to Drug Discovery and Target Identification? A Case Study of Anti-Diabetes II”

Session 2: Chronic Diseases in China

Cardiovascular and Metabolic Diseases Research

• Chairpersons: Kenneth R Chien, Director, Cardiovascular Research Center, Massachusetts General Hospital; Department of Cell Biology, Harvard Medical School, and Harvard Stem Cell Institute and Yu-Lung Lau, Head, Department of Paediatrics and Adolescent Medicine, The University of Hong Kong

• Karen Lam,
  Department of Medicine, The University of Hong Kong
  “Diabetes in Chinese: Changing Epidemiology and Novel Biomarkers”
• Alice Mascette,
  Heart Failure and Arrhythmias Branch, National Heart, Lung and Blood Institute, National Institutes of Health
  “NHLBI Investment in Cardiovascular Medicine”

Conference Banquet

• Bayview Room, The Hong Kong Country Club

Session 3: Fostering innovation in China

Biotechnology and Biopharmaceutical Opportunities in China

• Chairpersons: Dennis Lo, Director, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong and Michael Sjostrom, Chief Investment Officer, Sectoral Asset Management Inc.

• Ling Chen,
  Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences
  “Building an Integrated Biomedical Research Institute for Innovative Medicine in China”
• Paul Vanhoutte,
  Department of Pharmacology, The University of Hong Kong
  “Interactions between Academic Research and Industry in Drug Discovery”

Biotechnology and Biopharmaceutical Opportunities in China

• Chairpersons: Carlos Genardini, CEO, Hong Kong Science and Technology Parks Corp. and Michael Sjostrom, Chief Investment Officer, Sectoral Asset Management Inc.

• En Li,
  Head, Novartis Institutes for BioMedical Research, China
  “Novartis R&D Center in Shanghai - Finding Cures for Diseases of High Prevalence in China”

Intellectual Property in China

• Li Chen,
  Head of Research, Roche R&D Centre China
  “Drug Discovery Research that Creates IPR in China”

Session 4: Mining China's resources

Financing and Fundraising in China

• Chairpersons: David Ho, Director & CEO, Aaron Diamond AIDS Research Center; Irene Diamond Professor, The Rockefeller University and Paul Cheung, Professor, Department of Electrical and Electronic Engineering, The University of Hong Kong

• Zhu Chen,
  Vice-President, Chinese Academy of Sciences
  “Opportunities and Challenges for Biomedical Research in China”
• Gerald Chan,
  Morningside Group
  “Financing China's Biotechnology Industry”

Clinical Trials

• Chairpersons: David Ho, Director & CEO, Aaron Diamond AIDS Research Center; Irene Diamond Professor, The Rockefeller University and Kwok-Yung Yuen, Head, Department of Microbiology, The University of Hong Kong

• Johan Karlberg,
  Clinical Trials Centre, The University of Hong Kong
  “Emerging Locations for Conduct of Clinical Trials”
• James Cai,
  Vice President, Research, AstraZeneca Pharmaceutical Company, China.
  “In China for China, In China for Global”
• Evan Loh,
  Vice-President, Clinical R & D, Wyeth Pharmaceuticals

Presentation of Best Poster Award